Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Colorectal Neoplasms 6Stomach Neoplasms 5Sarcoma 2Endometrial Neoplasms 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Postoperative Complications 1Pancreatectomy 1Ovarian Neoplasms 1Neoplasms 1Motor Activity 1Lymphoma, Follicular 1Lung Neoplasms 1Heart Defects, Congenital 1Gynecologic Surgical Procedures 1Gynecologic Cancer 1Gastrointestinal Neoplasms 1Frailty 1Coma 1Colonic Neoplasms 1Cerebrovascular Disorders 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Brain Injuries, Traumatic 1

Interventions

Carboplatin 346Cisplatin 240Paclitaxel 208Radiotherapy 207Pemetrexed 190Docetaxel 170Gemcitabine 158pembrolizumab 147Erlotinib Hydrochloride 111Magnetic Resonance Spectroscopy 102Etoposide 99Bevacizumab 96Specimen Handling 84Nivolumab 77Radiosurgery 74durvalumab 73Blood Specimen Collection 65Drug Therapy 61osimertinib 56Vinorelbine 54Gefitinib 50Surveys and Questionnaires 48atezolizumab 45Biopsy 43Radiation 42Irinotecan 42Topotecan 39Standard of Care 39Cyclophosphamide 38Surgical Procedures, Operative 35

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lung Neoplasms × Enhanced Recovery After Surgery × Clear all
NCT04451473 2022-11-16

Lung Surgery With Enhanced Recovery VS. Lung Surgery Without Enhanced Recovery

The Second Hospital of Shandong University

Phase NA Recruiting
350 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡